SCHEMBL25540459

SCHEMBL25540459

CC1(C)c2ccc3ccccc3c2-c2cccc(-c3ccc(-c4nc(-c5ccc(-c6ccccc6)cc5)cc(-c5cccc(-c6ccccc6)c5)n4)c4ccccc34)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 2/20 0.35
RARB P10826 2/20 0.35
RARG P13631 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
PIM1 P11309 1/20 0.34
ALDH1A1 P00352 5/20 0.33
MAPT P10636 5/20 0.33
HPGD P15428 5/20 0.33
KDM4E B2RXH2 4/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
LMNA P02545 2/20 0.33
GLA P06280 1/20 0.33
PSD A5PKW4 1/20 0.32
ACACA Q13085 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539562 1.00 RARA (0.35) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25540307 0.99 ALDH1A1 (0.33) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25539557 0.99 ALDH1A1 (0.33) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25539671 0.99 RARA (0.36) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25539561 0.97 CYP1A1 (0.34) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25540305 0.97 CYP1A1 (0.34) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25539555 0.97 CYP1A1 (0.34) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25540457 0.97 CYP1A1 (0.34) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25539579 0.96 CYP1A1 (0.41) RARARARBRARGCYP1A1CYP1B1
SCHEMBL25539575 0.95 CYP1A1 (0.39) RARARARBRARGCYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM RARA 1983/4885RARB 2656/4885RARG 2824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.